###### Strengths and limitations of this study

-   This is the first study to compare National Cancer Patient Experience Survey responders directly to the wider cancer population diagnosed with the most common cancers in England.

-   The large sample size allowed a detailed comparison of demographic characteristics and tumour stage at diagnosis.

-   Data completeness for stage and ethnicity information in the cancer registry data were lower for patients diagnosed before 2012.

Introduction {#s1}
============

Patient experience surveys now play a major role internationally in assessing patients' care experiences, monitoring services and improving care quality and outcomes.[@R1] In England, there has been an increasing emphasis on improving patients' experiences of National Health Service (NHS) cancer care.[@R10] The National Cancer Patient Experience Survey (CPES) has invited a large sample of patients who received cancer care for all cancer types annually since 2010 to report their experiences.[@R12] These data are fed back to local NHS Cancer Services, reported nationally and used for policy development and research. Studies published from different years of CPES indicate that experiences have been improving across many domains but that systematic differences in cancer patient experience by patient sociodemographic factors remain.[@R13]

Although population-based health experience surveys provide a valuable patient perspective on many aspects of health services, they are prone to selection biases[@R18] that might result from missing the experiences of ethnic minorities, people living in the more deprived areas and the youngest and oldest age groups. In addition, there has been a concern that patients with the poorest prognosis are missed, because they are too ill or die before they can complete the survey.[@R20] Analysis of early cancer experience surveys in England in 2000 and 2004, for example, showed limited inclusion of lung cancer patients,[@R10] and analysis of CPES data for 2010 raised a concern about the number of patients in the initial sampling frame for some cancer types who died before they could receive they survey.[@R20]

The National Cancer Registration and Analysis Service (NCRAS) collects data on all incident cancer diagnoses in England.[@R22] Focusing on the four most common cancers in England (colorectal, lung, breast and prostate), we aimed to compare the survey responders' demographic and tumour stage at diagnosis and their median survival time to determine the extent to which they represent the cancer registry population and to inform future surveys.

Methods {#s2}
=======

CPES data linkage {#s2-1}
-----------------

CPES is conducted by Quality Health on behalf of NHS England and contains around 70 questions covering many aspects of cancer care experience ranging from seeing the general practitioner, receiving in-patient care and treatment to outpatient follow-up. For the analysis presented here, we focused on the four iterations of the survey between 2010 and 2014. The survey sampling frame includes all adult patients with a primary diagnosis of cancer who have been discharged from an NHS hospital either as an inpatient or day patient during a 3-month period in each year. Patients are invited to complete the survey by post, with two reminders being sent to non-responders. The response rate to the survey was stable (64%--68%) between 2010 and 2014. NCRAS has recently linked the CPES data set to the English population cancer registry through matching on patients unique identifier (NHS number) and the International Classification of Diseases (V.10) (ICD-10) 3-digit site code to enable researchers to explore the associations between cancer patients' experiences and their clinical outcomes.[@R23]

Study population {#s2-2}
----------------

NCRAS collects data on all cancers diagnosed in England. This includes demographic information, date of diagnosis, treatment and vital status through the Office for National Statistics.[@R22] The survey, however, includes only patients discharged in a recent 3-month period from hospital, regardless of their date of diagnosis. We found that for lung and colorectal cancer at least 95% of survey responders had their cancer diagnosed between 2007 and 2013, while 95% of responders with breast and prostate cancers were diagnosed between 2001 and 2013 ([figure 1](#F1){ref-type="fig"}). Thus, we extracted data for all patients diagnosed in those time periods with colorectal (C18-20), lung (C33-34), female breast (C50) and prostate (C61) cancers (ICD-10) from the cancer registration data (2016 closedown).[@R22]

![Study participants flow chart. All cancer incidences were first extracted. National Cancer Patient Experience Survey (CPES) responders were then separated from cancer registry population before randomly matching 1:1 on cancer diagnosis and quarter year of diagnosis.](bmjopen-2019-034344f01){#F1}

Cancer in situ (stage 0), patients aged less than 18 years, and diagnoses based on death certificates only (not found among CPES responders) were excluded. We also excluded cases with unknown vital status. In addition, some patients have responded to the survey more than once for the same type of cancer. Therefore, out of 3673 cases excluded in CPES cohort, 3442 were due to being multiple records ([figure 1](#F1){ref-type="fig"}).

We first removed all CPES responders from the cancer registry population. In order to make a fair comparison in terms of the follow-up time, diagnosis date, and data completeness, which changed over time, we randomly selected one patient who was not a CPES responder for each CPES responder, matched on cancer type and time of diagnosis (same yearly quarter) (n=103 186) ([figure 2](#F2){ref-type="fig"}). To assess the robustness of our method, we repeated this method by taking another random sample from the cancer registry. We compared the two random samples and there were no differences with regard to sex, age, ethnicity, and socioeconomic deprivation, geographical area of residence, disease stage and survival.

![Distribution of year of diagnosis of the cancer registry compared with National Cancer Patient Experience Survey (CPES) and the sample we took for colorectal, lung, breast and prostate cancers. This graph shows the year of diagnosis for the entire cancer registry population compared with the CPES responders, and the study sample we took from the entire cancer registry population based on random matching with CPES responders on cancer type and quarter year of diagnosis.](bmjopen-2019-034344f02){#F2}

For all patients, we included demographic data (sex, age, ethnicity, socioeconomic deprivation and geographical area of residence) and their survival and disease stage at diagnosis. Self-reported ethnicity data are obtained through linkage with the admitted patient care Hospital Episode Statistics (HES) data.[@R24] We collapsed the 16-group classification into six categories: White, Asian, Black, Chinese, Mixed and Other. Patient's socioeconomic deprivation is assigned based on their postcode of residence at diagnosis, and based on the quintile distribution of lower layer super output areas (LSOAs), which covers around 1500 persons, using the income domain of the index of multiple deprivation (IMD) (with 1 being the least deprived and 5 being the most deprived).[@R25] Four versions of IMD were available (2004, 2007, 2010, 2015) and we applied the closest match of IMD to the year of diagnosis (IMD 2004 for diagnosis years 1999--2002; IMD 2007 for diagnosis years 2003--2006; IMD 2010 for diagnosis years 2007--2009; IMD 2015 for diagnosis years 2010--2013). Information on disease stage was extracted from the cancer registry system for all cancers, and for lung cancer missing stage information was extracted from the National Lung Cancer Audit data set, which has a higher completeness of lung cancer stage data.[@R26]

Data analysis {#s2-3}
-------------

A total number of 206 372 patients were included in the analysis. We first compared the distribution of the patient characteristics (age, sex, socioeconomic deprivation, ethnicity, geographical areas) and disease stage among CPES responders and the cancer registry population using univariable and multivariable logistic regression. χ² tests were performed to estimate the p-values for trend and heterogeneity excluding missing value categories, where p-values for trend were estimated by fitting the categorical variables linearly. We calculated survival time from the date of diagnosis until date of death. Patients who were still alive were censored on their last updated live status date in the cancer registration (between 5 and 10 January 2018). Where the date of death and date of diagnosis had the same date, we added 0.1 day to cancer registry population survival time (breast: (n=2108), prostate: (n=3140), lung: (n=5436) and colorectal: (n=2617)). Finally, we compared median patient survival (in years) between the two groups using the Mann-Whitney test. All analyses were performed using Stata Software V.15 (StataCorp).

Results {#s3}
=======

[Tables 1--4](#T1 T2 T3 T4){ref-type="table"} show the odds of being in the CPES group based on patient and tumour stage at diagnosis. Males were more likely to have responded to CPES than females among colorectal cancer patients but not among lung cancer patients (colorectal: adjusted OR 1.06, 95% CI: 1.02 to 1.10; lung: adjusted OR 0.96, 95% CI: 0.91 to 1.01). CPES responders were significantly younger than their registry counterparts across all cancers (median age: colorectal 68 vs 74 years, p\<0.001; lung 68 vs 73 years, p\<0.001; breast 58 vs 64 years, p\<0.001; prostate 67 vs 71 years, p\<0.001). Patients with a non-White ethnic background were less likely to be in the CPES cohort across all cancers, although this was most statistically significant among people with an Asian background (colorectal: adjusted OR 0.67, 95% CI: 0.57 to 0.80; lung: adjusted OR 0.73, 95% CI: 0.57 to 0.94; breast: adjusted OR 0.67, 95% CI: 0.61 to 0.74; prostate: adjusted OR 0.79, 95% CI: 0.65 to 0.96). In addition, breast and prostate cancer patients from black ethnic background were less likely to be in the CPES cohort (breast: adjusted OR 0.81, 95% CI: 0.72 to 0.92; prostate: adjusted OR 0.82, 95% CI: 0.71 to 0.95),while patients from a Chinese ethnic background were less likely to be in the CPES cohort among breast cancer patients only (adjusted OR 0.67, 95% CI: 0.50 to 0.88).

###### 

Odds of colorectal cancer patients diagnosed between 2007 and 2013 having responded to CPES according to case mix

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                    CPES\        Cancer registry\   Univariable   Mutually adjusted\*                                                              
                              (n=25 832)   (non-CPES)\                                                                                                       
                                           (n=25 832)                                                                                                        
  --------------------------- ------------ ------------------ ------------- --------------------- ------------------------- ------------------------- ------ --------------
  Sex                                                                                                                                                        

   Female                     10 636       41.2               11 394        44.1                  reference                 reference                        

   Male                       15 196       58.8               14 438        55.9                  1.13                      1.09 to 1.17              1.06   1.02 to 1.10

   *Heterogeneity test*                                                                           χ2 (1)=45.4; p\<0.001     χ2 (1)=9.2; p=0.002              

  Age group                                                                                                                                                  

   \<30                       75           0.3                135           0.5                   0.86                      0.65 to 1.14              0.96   0.72 to 1.28

   30--44                     721          2.8                688           2.7                   1.63                      1.46 to 1.81              1.71   1.53 to 1.91

   45--59                     4431         17.2               3133          12.1                  2.19                      2.08 to 2.32              2.24   2.12 to 2.37

   60--74                     13 370       51.8               9801          37.9                  2.12                      2.03 to 2.20              2.13   2.04 to 2.21

   75--89                     7013         27.1               10 880        42.1                  reference                 reference                        

   90+                        222          0.9                1195          4.6                   0.29                      0.25 to 0.33              0.31   0.27 to 0.36

   *Trend test*                                                                                   χ2 (1)=1291.4; p\<0.001   χ2 (1)=1281.3; p\<0.001          

  Ethnicity                                                                                                                                                  

   White                      22 563       87.3               20 836        80.7                  reference                 reference                        

   Mixed                      43           0.2                46            0.2                   0.86                      0.57 to 1.31              0.87   0.56 to 1.33

   Asian                      260          1.0                330           1.3                   0.73                      0.62 to 0.86              0.67   0.57 to 0.80

   Black                      199          0.8                224           0.9                   0.82                      0.68 to 0.99              0.84   0.69 to 1.03

   Chinese                    35           0.1                30            0.1                   1.08                      0.66 to 1.76              0.98   0.60 to 1.62

   Other                      4            0.0                7             0.0                   0.53                      0.15 to 1.80              0.53   0.15 to 1.87

   Unknown                    2728         10.6               4359          17.0                  0.58                      0.55 to 0.61              0.65   0.61 to 0.69

   *Heterogeneity test*                                                                           χ2 (5)=20.0; p=0.001      χ2 (5)=22.8; p\<0.001            

  Area of residence                                                                                                                                          

   South East                 4116         15.9               4367          16.9                  reference                 reference                        

   East Midlands              2573         10.0               2215          8.6                   1.23                      1.15 to 1.32              1.07   0.99 to 1.15

   East of England            3075         11.9               3053          11.8                  1.07                      1.00 to 1.14              0.91   0.85 to 0.98

   London                     2373         9.2                2591          10.0                  0.97                      0.91 to 1.04              1.08   1.00 to 1.16

   North East                 1578         6.1                1457          5.6                   1.15                      1.06 to 1.25              1.14   1.04 to 1.24

   North West                 3222         12.5               3659          14.2                  0.93                      0.88 to 1.00              0.92   0.86 to 0.99

   South West                 3268         12.7               3117          12.1                  1.11                      1.04 to 1.19              1.02   0.95 to 1.09

   West Midlands              3060         11.8               2823          10.9                  1.15                      1.08 to 1.23              1.04   0.96 to 1.11

   Yorkshire and The Humber   2567         9.9                2550          9.9                   1.07                      1.00 to 1.14              0.99   0.92 to 1.07

   *Heterogeneity test*                                                                           χ2 (8)=89.5; p\<0.001     χ2 (8)=46.3; p\<0.001            

  Deprivation                                                                                                                                                

   1-(most affluent)          5988         23.2               5404          20.9                  reference                 reference                        

   2                          6370         24.7               5659          21.9                  1.02                      0.97 to 1.07              1.01   0.96 to 1.07

   3                          5500         21.3               5430          21.0                  0.91                      0.87 to 0.96              0.92   0.87 to 0.97

   4                          4551         17.6               4938          19.1                  0.83                      0.79 to 0.88              0.84   0.79 to 0.89

   5-(most deprived)          3423         13.3               4401          17.0                  0.7                       0.66 to 0.74              0.69   0.65 to 0.73

   *Trend test*                                                                                   χ2 (1)=184.1; p\<0.001    χ2 (1)=164.9; p\<0.001           

  Stage                                                                                                                                                      

   I                          2155         8.3                2473          9.6                   reference                 reference                        

   II                         4404         17.0               3687          14.3                  1.37                      1.27 to 1.47              1.48   1.37 to 1.60

   III                        6381         24.7               3784          14.6                  1.94                      1.80 to 2.08              1.93   1.80 to 2.08

   IV                         3726         14.4               4845          18.8                  0.88                      0.82 to 0.95              0.91   0.84 to 0.98

   Not known                  9166         35.5               11 043        42.7                  0.95                      0.89 to 1.02              1.08   1.01 to 1.15

   *Trend test*                                                                                   χ2 (1)=14.2; p\<0.001     χ2 (1)=12.5; p\<0.001            
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Multivariable model including all factors; unknown stage and ethnicity categories were not included in tests for heterogeneity and trend.

CPES, National Cancer Patient Experience Survey.

###### 

Odds of lung cancer patients diagnosed between 2007 and 2013 having responded to CPES according to case mix

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                    CPES\        Cancer registry (non-CPES)\   Univariable   Mutually adjusted\*                                                                 
                              (n=12 942)   (n=12 942)                                                                                                                      
  --------------------------- ------------ ----------------------------- ------------- ------------------------ ------------------------- ------------------------- ------ --------------
  Sex                                                                                                                                                                      

   Female                     5968         46.1                          5793          44.8                     reference                 reference                        

   Male                       6974         53.9                          7149          55.2                     0.95                      0.90 to 0.99              0.96   0.91 to 1.01

   *Heterogeneity test*                                                                χ2 (1)=4.7; p=0.02       χ2 (1)=2.6; p=0.10                                         

  Age group                                                                                                                                                                

   \<30                       13           0.1                           16            0.1                      0.58                      0.28 to 1.21              0.73   0.34 to 1.56

   30--44                     148          1.1                           119           0.9                      0.89                      0.70 to 1.14              1.05   0.81 to 1.35

   45--59                     2144         16.6                          1406          10.9                     1.09                      1.01 to 1.18              1.19   1.10 to 1.28

   60--74                     7681         59.3                          5513          42.6                     reference                 reference                        

   75--89                     2922         22.6                          5397          41.7                     0.39                      0.37 to 0.41              0.38   0.36 to 0.41

   90+                        34           0.3                           491           3.8                      0.05                      0.04 to 0.07              0.05   0.04 to 0.07

   *Trend test*                                                                                                 χ2 (1)=1165.7; p\<0.001   χ2 (1)=1174.2; p\<0.001          

  Ethnicity                                                                                                                                                                

   White                      11 566       89.4                          10 287        79.5                     reference                 reference                        

   Mixed                      23           0.2                           19            0.1                      1.08                      0.59 to 1.98              0.75   0.40 to 1.39

   Asian                      128          1.0                           151           1.2                      0.75                      0.59 to 0.96              0.73   0.57 to 0.94

   Black                      80           0.6                           82            0.6                      0.87                      0.64 to 1.18              0.82   0.59 to 1.14

   Chinese                    19           0.1                           14            0.1                      1.21                      0.60 to 2.41              1.00   0.48 to 2.09

   Other                      4            0.1                           5             0.1                      0.71                      0.19 to 2.65              0.57   0.15 to 2.18

   Unknown                    1122         8.7                           2384          18.4                     0.42                      0.39 to 0.45              0.49   0.45 to 0.54

   *Heterogeneity test*                                                                χ2 (5)=6.8; p=0.23       χ2 (5)=7.4; p=0.1                                          

  Area of residence                                                                                                                                                        

   South East                 1631         12.6                          1903          14.7                     reference                 reference                        

   East Midlands              1266         9.8                           1070          8.3                      1.38                      1.24 to 1.53              1.35   1.21 to 1.51

   East of England            1475         11.4                          1368          10.6                     1.26                      1.14 to 1.39              1.17   1.05 to 1.30

   London                     1320         10.2                          1359          10.5                     1.13                      1.02 to 1.25              1.36   1.21 to 1.52

   North East                 1034         8.0                           944           7.3                      1.28                      1.14 to 1.43              1.27   1.13 to 1.44

   North West                 1808         14.0                          2229          17.2                     0.95                      0.86 to 1.04              0.94   0.85 to 1.04

   South West                 1349         10.4                          1229          9.5                      1.28                      1.16 to 1.42              1.21   1.09 to 1.35

   West Midlands              1354         10.5                          1302          10.1                     1.21                      1.10 to 1.34              1.18   1.06 to 1.32

   Yorkshire and The Humber   1705         13.2                          1538          11.9                     1.29                      1.18 to 1.42              1.25   1.12 to 1.39

   *Heterogeneity test*                                                                χ2 (8)=104.9; p\<0.001   χ2 (8)=86.7; p\<0.001                                      

  **Deprivation**                                                                                                                                                          

   1 (most affluent)          2047         15.8                          1726          13.3                     reference                 reference                        

   2                          2603         20.1                          2251          17.4                     1.04                      0.96 to 1.13              1.00   0.91 to 1.09

   3                          2662         20.6                          2595          20.1                     0.92                      0.84 to 1.00              0.85   0.78 to 0.93

   4                          2733         21.1                          2880          22.3                     0.83                      0.77 to 0.90              0.75   0.68 to 0.82

   5 (most deprived)          2897         22.4                          3490          27.0                     0.77                      0.71 to 0.84              0.65   0.60 to 0.71

   *Trend test*                                                                                                 χ2 (1)=73.4; p\<0.001     χ2 (1)=135.5; p\<0.001           

  **Stage**                                                                                                                                                                

   I                          2170         16.8                          1422          11.0                     reference                 reference                        

   II                         1672         12.9                          765           5.9                      1.43                      1.28 to 1.60              1.40   1.25 to 1.56

   III                        3759         29.0                          2333          18.0                     1.06                      0.97 to 1.15              1.00   0.91 to 1.09

   IV                         4210         32.5                          6170          47.7                     0.45                      0.41 to 0.48              0.42   0.38 to 0.45

   Not known                  1131         8.7                           2252          17.4                     0.33                      0.30 to 0.36              0.36   0.33 to 0.40

   *Trend test*                                                                                                 χ2 (1)=696.9; p\<0.001    χ2 (1)=713.7; p\<0.001           
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Multivariable model including all factors; unknown stage and ethnicity categories were not included in tests for heterogeneity and trend.

CPES, National Cancer Patient Experience Survey.

###### 

Odds of breast cancer patients diagnosed between 2001 and 2013 having responded to CPES according to case mix

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                    CPES\        Cancer registry (non-CPES)\   Univariable   Mutually adjusted\*                                                              
                              (n=43 966)   (n=43 966)                                                                                                                   
  --------------------------- ------------ ----------------------------- ------------- --------------------- ------------------------- ------------------------- ------ --------------
  Age group                                                                                                                                                             

   \<30                       257          0.6                           221           0.5                   1.06                      0.88 to 1.27              1.05   0.88 to 1.27

   30--44                     5907         13.4                          3921          8.9                   1.37                      1.31 to 1.43              1.34   1.28 to 1.41

   45--59                     17 517       39.8                          12 761        29.0                  1.25                      1.21 to 1.29              1.23   1.19 to 1.27

   60--74                     15 991       36.4                          14 520        33.0                  reference                 reference                        

   75--89                     4175         9.5                           10 825        24.6                  0.35                      0.34 to 0.37              0.34   0.33 to 0.35

   90+                        119          0.3                           1718          3.9                   0.06                      0.05 to 0.08              0.06   0.05 to 0.08

   *Trend test*                                                                                              χ2 (1)=3984.3; p\<0.001   χ2 (1)=3857.5; p\<0.001          

  Ethnicity                                                                                                                                                             

   White                      36 329       82.6                          33 022        75.1                  reference                 reference                        

   Mixed                      146          0.3                           138           0.3                   0.96                      0.76 to 1.21              0.74   0.58 to 0.94

   Asian                      912          2.1                           964           2.2                   0.86                      0.78 to 0.94              0.67   0.61 to 0.74

   Black                      576          1.3                           539           1.2                   0.97                      0.86 to 1.09              0.81   0.72 to 0.92

   Chinese                    100          0.2                           104           0.2                   0.87                      0.66 to 1.15              0.67   0.50 to 0.88

   Other                      30           0.1                           24            0.1                   1.14                      0.66 to 1.94              0.84   0.48 to 1.45

   Unknown                    5873         13.4                          9175          20.9                  0.58                      0.56 to 0.60              0.63   0.60 to 0.65

   *Heterogeneity test*                                                                                      χ2 (5)=11.7; p=0.03       χ2 (5)=76.1; p\<0.001            

  Area of residence                                                                                                                                                     

   South East                 7040         16.0                          8010          18.2                  reference                 reference                        

   East Midlands              4264         9.7                           3741          8.5                   1.30                      1.23 to 1.37              1.16   1.10 to 1.23

   East of England            5135         11.7                          5025          11.4                  1.16                      1.11 to 1.22              1.00   0.94 to 1.05

   London                     5069         11.5                          5320          12.1                  1.08                      1.03 to 1.14              1.15   1.09 to 1.21

   North East                 2417         5.5                           2118          4.8                   1.30                      1.21 to 1.39              1.14   1.07 to 1.23

   North West                 4787         10.9                          6080          13.8                  0.90                      0.85 to 0.94              0.88   0.84 to 0.93

   South West                 5364         12.2                          5016          11.4                  1.22                      1.16 to 1.28              1.11   1.05 to 1.17

   West Midlands              5250         11.9                          4509          10.3                  1.32                      1.26 to 1.39              1.20   1.14 to 1.27

   Yorkshire and The Humber   4640         10.6                          4147          9.4                   1.27                      1.21 to 1.34              1.11   1.05 to 1.18

   *Heterogeneity test*                                                                                      χ2 (8)=372.0; p\<0.001    χ2 (8)=178.5; p\<0.001           

  Deprivation                                                                                                                                                           

   1 (most affluent)          10 154       23.1                          9883          22.5                  reference                 reference                        

   2                          10 510       23.9                          9905          22.5                  1.03                      0.99 to 1.07              1.04   0.99 to 1.08

   3                          9452         21.5                          9204          20.9                  1                         0.96 to 1.04              1.00   0.96 to 1.04

   4                          7835         17.8                          8080          18.4                  0.94                      0.91 to 0.98              0.95   0.91 to 0.99

   5 (most deprived)          6015         13.7                          6894          15.7                  0.85                      0.81 to 0.89              0.84   0.80 to 0.88

   *Trend test*                                                                                              χ2 (1)=60.4; p\<0.001     χ2 (1)=73.6; p\<0.001            

  Stage                                                                                                                                                                 

   I                          11 956       27.2                          12 939        29.4                  reference                 reference                        

   II                         14 047       31.9                          10 685        24.3                  1.42                      1.37 to 1.47              1.54   1.49 to 1.60

   III                        3983         9.1                           2377          5.4                   1.81                      1.71 to 1.92              1.90   1.79 to 2.02

   IV                         1385         3.2                           2159          4.9                   0.69                      0.65 to 0.75              0.84   0.78 to 0.91

   Not known                  12 595       28.6                          15 806        36.0                  0.86                      0.83 to 0.89              1.06   1.02 to 1.10

   *Trend test*                                                                                              χ2 (1)=63.7; p\<0.001     χ2 (1)=157.3; p\<0.001           
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*\*Multivariable model including all factors; unknown stage and ethnicity categories were not included in tests for heterogeneity and trend.

CPES, National Cancer Patient Experience Survey.

###### 

Odds of prostate cancer patients diagnosed between 2001 and 2013 having responded to CPES according to case mix

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                    CPES\        Cancer registry (non-CPES)\   Univariable   Mutually adjusted\*                                                                 
                              (n=20 446)   (n=20 446)                                                                                                                      
  --------------------------- ------------ ----------------------------- ------------- ------------------------ ------------------------- ------------------------- ------ --------------
  Age group                                                                                                                                                                

   \<44                       36           0.2                           43            0.2                      0.68                      0.44 to 1.07              0.71   0.45 to 1.12

   45--59                     2999         14.7                          2106          10.3                     1.11                      1.04 to 1.18              1.15   1.08 to 1.23

   60--74                     13 499       66                            10 511        51.4                     reference                 reference                        

   75--89                     3870         18.9                          7241          35.4                     0.42                      0.40 to 0.44              0.41   0.39 to 0.43

   90+                        42           0.2                           545           2.7                      0.06                      0.04 to 0.08              0.06   0.04 to 0.08

   *Trend test*                                                                                                 χ2 (1)=1501.4; p\<0.001   χ2 (1)=1542.7; p\<0.001          

  Ethnicity                                                                                                                                                                

   White                      17 205       84.1                          15 132        74.0                     reference                 reference                        

   Mixed                      48           0.2                           42            0.2                      1.01                      0.66 to 1.52              0.96   0.62 to 1.46

   Asian                      204          1.1                           235           1.1                      0.76                      0.63 to 0.92              0.79   0.65 to 0.96

   Black                      396          1.9                           449           2.2                      0.78                      0.68 to 0.89              0.82   0.71 to 0.95

   Chinese                    58           0.3                           63            0.3                      0.81                      0.57 to 1.16              0.83   0.58 to 1.20

   Other                      24           0.1                           8             0.1                      2.64                      1.19 to 5.87              2.29   1.02 to 5.16

   Unknown                    2511         12.3                          4517          22.1                     0.49                      0.46 to 0.52              0.49   0.46 to 0.51

   *Heterogeneity test*                                                                χ2 (5)=27.7; p\<0.001    χ2 (5)=16.6; p=0.005                                       

  Area of residence                                                                                                                                                        

   South East                 2802         13.7                          3677          18.0                     reference                 reference                        

   East Midlands              2015         9.9                           1712          8.4                      1.54                      1.42 to 1.67              1.47   1.35 to 1.60

   East of England            2378         11.6                          2613          12.8                     1.19                      1.11 to 1.29              1.14   1.05 to 1.24

   London                     1959         9.6                           2316          11.3                     1.11                      1.03 to 1.20              1.21   1.11 to 1.31

   North East                 989          4.8                           907           4.4                      1.43                      1.29 to 1.59              1.42   1.27 to 1.58

   North West                 3737         18.3                          2508          12.3                     1.96                      1.82 to 2.10              2.04   1.89 to 2.19

   South West                 2721         13.3                          2504          12.2                     1.43                      1.33 to 1.53              1.34   1.24 to 1.45

   West Midlands              2215         10.8                          2217          10.8                     1.31                      1.21 to 1.42              1.26   1.16 to 1.36

   Yorkshire and The Humber   1630         8.0                           1992          9.7                      1.07                      0.99 to 1.17              1.05   0.96 to 1.14

   *Heterogeneity test*                                                                χ2 (8)=470.1; p\<0.001   χ2 (8)=459.8; p\<0.001                                     

  Deprivation                                                                                                                                                              

   1 (most affluent)          5198         25.4                          5019          24.5                     reference                 Reference                        

   2                          5228         25.6                          4886          23.9                     1.03                      0.98 to 1.09              1.01   0.95 to 1.07

   3                          4159         20.3                          4261          20.8                     0.94                      0.89 to 1.00              0.94   0.88 to 1.00

   4                          3278         16.0                          3463          16.9                     0.91                      0.86 to 0.97              0.90   0.84 to 0.96

   5 (most deprived)          2583         12.6                          2817          13.8                     0.89                      0.83 to 0.95              0.83   0.78 to 0.90

   *Trend test*                                                                                                 χ2 (1)=24.3; p\<0.001     χ2 (1)=40.5; p\<0.001            

  Stage                                                                                                                                                                    

   I                          3081         15.1                          3044          14.9                     reference                 Reference                        

   II                         3032         14.8                          2560          12.5                     1.37                      1.27 to 1.47              1.20   1.12 to 1.30

   III                        2279         11.1                          1791          8.8                      1.93                      1.08 to 2.07              1.26   1.16 to 1.37

   IV                         2103         10.3                          2156          10.5                     0.88                      0.82 to 0.94              1.14   1.05 to 1.24

   Not known                  9951         48.7                          10 895        53.3                     0.95                      0.89 to 1.02              1.08   1.01 to 1.14

   *Trend test*                                                                                                 χ2 (1)=0.0; p=0.7         χ2 (1)=12.9; p\<0.001            
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Multivariable model including all factors; unknown stage and ethnicity categories were not included in tests for heterogeneity and trend.

CPES, National Cancer Patient Experience Survey.

In addition, living in more deprived areas was associated with the reduced odds of being in the CPES group across all cancers: colorectal (adjusted OR 0.69, 95% CI: 0.65 to 0.73 for most vs least deprived), lung (adjusted OR 0.65, 95% CI: 0.60 to 0.71 for most vs least deprived), breast (adjusted OR 0.84, 95% CI: 0.80 to 0.88 for most vs least deprived) and prostate (adjusted OR 0.83, 95% CI: 0.78 to 0.90 for most vs least deprived). Generally, CPES responders were more likely to be resident in areas other than the South East or North West. However, among prostate cancer patients, responders to the CPES were most likely to be resident in the North West (adjusted OR 2.04, 95% CI: 1.89 to 2.19 for North West vs South East).

In general, when comparing cancer stage at diagnosis between the two cohorts, CPES responders were more likely to be diagnosed with stage II and III disease and less likely to be diagnosed with stage IV disease. The proportions of missing stage information were lower among CPES responders across all cancers. CPES responders with colorectal and breast cancers were more likely to be diagnosed with stage II (colorectal: adjusted OR 1.48, 95% CI: 1.37 to 1.60; breast: adjusted OR 1.54, 95% CI: 1.49 to 1.60), and III (colorectal: adjusted OR 1.93, 95% CI: 1.80 to 2.08; breast: adjusted OR 1.90, 95% CI: 1.79 to 2.02) while CPES responders with lung cancer patients were more likely to be diagnosed with stage II (adjusted OR 1.40, 95% CI: 1.25 to 1.60). Survey responders had a significantly higher median survival compared with the cancer registry population across all cancers, with the largest difference in lung cancer and colorectal cancer (colorectal: 4.8 vs 3.2 years, p\<0.001; breast: 5.7 vs 5.4 years, p\<0.001; and prostate: 5.7 vs 5.2 years, p\<0.001; lung: 2.0 vs 0.3 years, p\<0.001).

Discussion {#s4}
==========

Summary of main findings {#s4-1}
------------------------

This study examined how representative CPES responders for the four main cancers are compared with the cancer registry population with respect to individual characteristics and tumour stage at diagnosis. Overall, survey responders were younger, more likely to have a White ethnic background, to be living in less deprived areas and diagnosed at stages II and III across all cancer types. There was a small difference by sex among patients with colorectal cancer with males being more likely to be in the CPES responder group than females, but not for those with lung cancer. Median survival was generally higher in CPES responders, although the magnitude varied across different cancers and was most pronounced in lung and colorectal cancer patients.

Comparison with other findings {#s4-2}
------------------------------

Our findings concerning the limited representativeness of the survey responders compared with the cancer registry population are consistent with two previous studies.[@R10] Abel and colleagues examined those selected into the initial CPES sampling frame and found non-responders were more likely to be older, from more deprived areas, or diagnosed with poor prognosis cancers. These patients were more likely to have died in the 2--3 month period between the initial sampling and the mail out of the survey and so never received the survey.[@R20] The variation in median survival between the survey responders and the cancer registry population in our study, especially for lung cancer, is very likely related to this issue but may also represent patients who received the survey but were too ill to complete and return it. Abel *et al*[@R20] findings are important when comparing CPES responders versus non-responders. However, their study focused on internal representativeness only, whereas we sought to address the question of how representative the CPES responders are of all patients diagnosed with one of the four most common cancers, and not only those who have had an inpatient experience. Although our findings are similar and align with theirs, our study is important when comparing the responders to wider cancer population with these cancer types. This is particularly important when using CPES findings to inform cancer care policy for all English patients.

It is of interest that CPES responders were more likely to be diagnosed with stage II or III disease compared with stage I. This may reflect a higher intensity of treatment through which they were more likely to be included in the sampling frame. Moreover, the low inclusion of patients with lung cancer patients as a proportion of the incidence is consistent with another study which found that the initial 2000 and 2004 patient experience surveys did not represent patients registered with lung cancer in South East England (the response rate for lung patients was between 6% and 28% in 2000 and 2004, respectively).[@R10]

Strengths and limitations of this study {#s4-3}
---------------------------------------

To our knowledge, this study is the first to compare CPES responders directly to the cancer registry population using the CPES--NCRAS data linkage. One strength of our study is the large sample size, which allowed for detailed comparison of demographic and tumour stage at diagnosis between CPES responders and cancer registration patients for the four different cancer types. While most of CPES responders for every survey year were recently diagnosed patients admitted and discharged from cancer care, CPES has a backward tail of patients diagnosed in previous years, representing long-term survivors. The cancer registry population on the other hand is the annual cumulative incidence of all cancers diagnosed. We randomly selected one patient who was not a CPES responder for each CPES responder matched on cancer site and period of diagnosis (same yearly quarter) to eliminate survival time bias, and to get similar level of stage and ethnicity data completeness for both groups.

We recognise that this study has several limitations. Although data completeness for stage and ethnicity at NCRAS has vastly improved since 2012,[@R22] a proportion of patients had missing information on disease stage and ethnicity. In addition, we extracted ethnicity information from the same data source to get a similar ethnicity completeness. Yet, ethnicity and stage completeness were slightly higher for the CPES group compared with the cancer registry population, which might be explained by CPES responders being more often admitted to hospital and therefore appearing more in the HES records.

Study implications {#s4-4}
------------------

CPES aims to capture patients' experiences across many aspects of their care pathway and has successfully guided cancer policy, the monitoring and improvement of experiences and the development of cancer services across England.[@R11] The survey data set is now linked to the cancer registry data, enabling researchers to explore more complex questions such as possible associations between cancer patients' experiences and their clinical outcomes. As we have shown, the representativeness of the data set to the population of cancer patients is limited in some areas and varies between the four cancer types. When using results generated from this data set, cancer policy makers, cancer care providers, patient advocates, charities and health researchers should therefore be aware of several limitations. First, our exploration of this data set found that most of the survey responders were diagnosed close to the survey sampling frame period. This is because the CPES sampling frame is based on a recent hospital treatment, so the patients recruited may not represent the care experience or perspective for all cancer patients. Second, patients responding to the survey were more likely to be diagnosed with earlier stage diseases, and to have a higher median survival. This leads to an under-representation of the experiences of patients with poor prognosis, which disproportionally affects certain cancer types. Patients excluded from the survey because of the sampling frame very likely have greater health needs including those for supportive and palliative care which the survey cannot capture.

In addition, there are notable differences in responders by cancer type by comparison with the cancer incidence registered every year in England. For example, out of all lung cancer incident cases diagnosed between 2011 and 2013 (incidents n=107 431), only 9% were captured in CPES (n=9381) compared with 22% (n=28 781) for breast cancer (incidents n=128 552).[@R27] As a consequence, the number of responses for individual cancer types may be too low to be reported and considered at a local level or to show improvement. This is particularly problematic for lung cancer---the most common cancer in males and females combined and the biggest killer of all the cancers.[@R28] Work is therefore needed to recruit more patients with poor prognosis cancers in particular, so that cancer services can be designed based on these patients' experiences and comments rather than on data from a mix of patients with other cancers. This might involve additional surveys that seek to capture experiences in the early part of the referral, investigation and diagnosis pathway from a larger number of patients. An alternative is to expand the current sampling frame or move to continuous sampling throughout the year for patients with poor prognosis cancers. For example, the Consumer Assessment of Healthcare Providers and Systems has made efforts and initiatives to capture unrepresented patients' voices.[@R29] Another example of a study including unrepresented patients is one carried in Denmark which aimed to capture lung cancer patient-reported outcomes at a nationwide level.[@R21] Future efforts should assess the feasibility of adopting similar methods for CPES as well as on the reasons behind the low response rates among patients with advanced stage disease, older patients and those from non-White ethnic backgrounds.

Conclusion {#s5}
==========

This study demonstrates that while CPES has been a valuable tool for the large-scale reporting of patient experience, it does not necessarily represent all cancer patients in terms of patient and tumour stage at diagnosis for the four main cancers. These limitations need to be acknowledged by cancer policy makers, charities, cancer services and patient representatives using the findings and by researchers interpreting results from the survey and the linked registry data set. Future research should examine the feasibility of applying either supplementary focused or more continuous surveys for the under-represented groups of patients to capture their missing care experiences.
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